Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.84 USD | +1.05% | +18.15% | +3.88% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 18.64M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.09
x | P/E ratio 2025 * |
-1.71
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.33% |
1 day | +0.53% | ||
1 week | +17.65% | ||
Current month | +16.92% | ||
1 month | -2.06% | ||
3 months | -14.22% | ||
6 months | +12.00% | ||
Current year | +2.80% |
Managers | Title | Age | Since |
---|---|---|---|
Hyung-Heon Kim
CEO | Chief Executive Officer | 47 | 21-07-08 |
Director of Finance/CFO | 66 | 23-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Strickland
BRD | Director/Board Member | 77 | 22-01-26 |
Andrew Koven
CHM | Chairman | 66 | 21-07-08 |
Mark Glickman
BRD | Director/Board Member | 58 | 23-05-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 3.84 | +1.05% | 37 723 |
24-05-06 | 3.8 | +0.53% | 12,823 |
24-05-03 | 3.78 | +1.34% | 22,131 |
24-05-02 | 3.73 | +1.36% | 14,956 |
24-05-01 | 3.68 | +13.23% | 60,065 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.80% | 18.64M | |
+9.15% | 106B | |
-1.08% | 104B | |
+7.19% | 23.25B | |
-11.55% | 22.5B | |
-7.10% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- NRBO Stock